학술논문

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Akce, MehmetAles Diaz, InmaculadaAlves, GustavoAnand, SumitraArslan, CagatayAsselah, JamilAssenat, EricAubin, FrancineBai, Li-YuanBai, YuxianBarajas, OlgaBates, SusanBegbie, StephenBen-Aharon, IritBeri, NinaBerres, Marie-LuiseBlanc, Jean-FredericBorbath, IvanBordonaro, RobertBouattour, MohamedBrandi, GiovanniBurgoyne, AdamButthongkomvong, KritiyaCamandaroba, MarcosCao, KeCarballido, MarcelaChan, Stephan LamChen, Jen-ShiChen, Ming-HuangChen, XiaomingCheng, AshleyChiu, Tai-JanChoi, Hye JinChon, Hong JaeCollignon, JoelleCubillo Gracian, AntonioDavis, Sarahde Carvalho, Ricardo Saraivade Groot, D.J.A.Demols, AnneDe Vos, JudithDiab, MariaEasaw, JacobEatock, MartinEdeline, JulienElias, RawadEskens, FredericusFalcone, AlfredoFernandez, PlinioFinn, RichardFranke, FabioFurukawa, MasayukiFuruse, JunjiGbolahan, OlumideGeboes, KarenGeneser, Keri-LeeGeng, ZhiminGeva, RavitGillmore, RoopinderGoetze, ThorstenGou, HongfengGrasselli, JulietaGu, ShanzhiGumus, MahmutHaj Mohammad, NadiaHao, ChunyiHarputluoglu, HakanHatoum, HassanHeinemann, VolkerHo, Wang KwongHsu, ChiunHubert, AyalaHwang, JuneulInanc, MevludeIseas, SoledadJeyasingam, VaishnaviJimenez Fonseca, PaulaJoubert, WarrenJuengsamarn, JitladaKaen, DiegoKanai, MasashiKasper-Virchow, StefanKazemi, GhazalehKelleher, FergalKelley, RobinKim, Jin WonKim, Jong GwangKinupe Abrahao, Ana BeatrizKlumpen, HeinzKochenderfer, MarkKose, FatihLam, Ho ChingLee, Choong-kunLee, Hyun WooLee, MargaretLee, Myung AhLee, Wai Man SarahLe Sourd, SamuelLi, DongliangLi, WeiLiang, HoujieLiang, TingboLim, Chun SenLingerfelt, BrianLopez, CharlesLow, JohnMacarulla Mercade, TeresaMalka, DavidMao, YiminMasi, GianlucaMcCune, StevenMcDermott, RayMcWhirter, ElaineMendez, GuillermoMilella, MicheleMizuno, NobumasaMizutani, TomonoriMoniz, CamilaMorales, LuisaMunoz Martin, Andres JesúsNervi, BrunoNgamphaiboon, NuttapongOh, Sang CheulOksuzoglu, BernaOutlaw, DarrylOzaka, MasatoOzguroglu, MustafaOzyilkan, OzgurPainemal, ClaudioPan, YueyinPark, Joon OhPelzer, UwePeng, ChuangPetorin, CarolinePezet, DenisPower, DerekQin, ShukuiRen, ZhenggangRoohullah, AflahRyu, HyewonSalman, PamelaSasaki, MitsuhitoSasidharan, RitaSatoh, TarohSchulze, KorneliusScott-Brown, MartinSegovia, RubenSeufferlein, ThomasSiena, SalvatoreSinapi, IsabelleSmolenschi, CristinaSong, TianqiangSookprasert, AumkhaeSoparattanapaisarn, NopadolStarling, NaureenStein, StaceyStemmer, SalomonSu, HaichuanSugimoto, RieSuksombooncharoen, ThatthanTam, VincentTan, Ai LianTan, Chih KiangTanasanvimon, SuebpongTonini, GiuseppeTortora, GiampaoloTsuji, AkihitoUeno, MakotoUribe, RodrigoVenerito, MarinoVerdaguer Mata, HelenaVerslype, ChrisVictorino, Ana PaulaVogel, ArndtWade, JamesWaldschmidt, Dirk ThomasWang, LuWan Isahk, Wan ZamaniahWasan, HarpeetWeschenfelder, RuiWong, Chun YinWong, Yoke FuiYalcin, SuayibYanez Weber, PatricioYang, XuezhongYasui, HisateruYau, ThomasYazici, OzanYen, Chia-JuiYing, JieerYoo, ChanghoonYu, WenchangZhao, HaitaoKelley, Robin KateFinn, Richard SKlümpen, Heinz-JosefChan, Stephen LValle, Juan WYu, LiMalhotra, UshaSiegel, Abby B
Source
In The Lancet 3-9 June 2023 401(10391):1853-1865
Subject
Primary Research
Articles
Language
ISSN
0140-6736